|
Name |
Miophytocen A
|
Molecular Formula | C29H38O8 | |
IUPAC Name* |
(1R,2S,3R,6Z,8E,10R,14E,19R,23R,24R,26R)-1-hydroxy-10-[(1R)-1-hydroxyethyl]-2,14,22-trimethyl-4,11,17,25-tetraoxapentacyclo[21.3.1.13,26.02,19.019,24]octacosa-6,8,14,21-tetraene-5,16-dione
|
|
SMILES |
C/C/1=C\C(=O)OC[C@]23CC=C([C@@H]4[C@H]2O[C@@H]5C[C@H]([C@]3([C@@]5(C4)O)C)OC(=O)/C=C\C=C\[C@@H](OCC1)[C@@H](C)O)C
|
|
InChI |
InChI=1S/C29H38O8/c1-17-10-12-34-21(19(3)30)7-5-6-8-24(31)36-22-14-23-29(33)15-20-18(2)9-11-28(26(20)37-23,27(22,29)4)16-35-25(32)13-17/h5-9,13,19-23,26,30,33H,10-12,14-16H2,1-4H3/b7-5+,8-6-,17-13+/t19-,20-,21-,22-,23-,26-,27-,28-,29+/m1/s1
|
|
InChIKey |
CMYUURXKIJZUGB-QZANRFNGSA-N
|
|
Synonyms |
Miophytocen A; 5T85BY9B6A; (9R-(3E,9R*(R*),10E,12Z,16R*,16As*,17R*,18R*,19ar*,20R*,23ar*))-6,7,16,16a,17,18,19a,20-octahydro-17-hydroxy-9-(1-hydroxyethyl)-5,16a,21-trimethyl-16,18:17,20-dimethano-1H,3H,23H-(1,6,12)trioxacyclooctadecino(3,4-d)(1)benzopyran-3,14(9H)-dione; 16,18:17,20-Dimethano-1H,3H,23H-(1,6,12)trioxacyclooctadecino(3,4-d)(1)benzopyran-3,14(9H)-dione, 6,7,16,16a,17,18,19a,20-octahydro-17-hydroxy-9-((1R)-1-hydroxyethyl)-5,16a,21-trimethyl-, (4E,9R,10E,12Z,16R,16aS,17R,18R,19aR,20R,23aR)-; 99764-49-5; UNII-5T85BY9B6A; Q27896945
|
|
CAS | 99764-49-5 | |
PubChem CID | 122201252 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 514.6 | ALogp: | 2.2 |
HBD: | 2 | HBA: | 8 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 112.0 | Aromatic Rings: | 6 |
Heavy Atoms: | 37 | QED Weighted: | 0.402 |
Caco-2 Permeability: | -5.107 | MDCK Permeability: | 0.00001380 |
Pgp-inhibitor: | 0.231 | Pgp-substrate: | 0.988 |
Human Intestinal Absorption (HIA): | 0.071 | 20% Bioavailability (F20%): | 0.697 |
30% Bioavailability (F30%): | 0.733 |
Blood-Brain-Barrier Penetration (BBB): | 0.234 | Plasma Protein Binding (PPB): | 83.11% |
Volume Distribution (VD): | 1.735 | Fu: | 6.26% |
CYP1A2-inhibitor: | 0.024 | CYP1A2-substrate: | 0.11 |
CYP2C19-inhibitor: | 0.394 | CYP2C19-substrate: | 0.593 |
CYP2C9-inhibitor: | 0.855 | CYP2C9-substrate: | 0.062 |
CYP2D6-inhibitor: | 0.025 | CYP2D6-substrate: | 0.101 |
CYP3A4-inhibitor: | 0.85 | CYP3A4-substrate: | 0.549 |
Clearance (CL): | 1.633 | Half-life (T1/2): | 0.828 |
hERG Blockers: | 0.799 | Human Hepatotoxicity (H-HT): | 0.738 |
Drug-inuced Liver Injury (DILI): | 0.147 | AMES Toxicity: | 0.198 |
Rat Oral Acute Toxicity: | 0.272 | Maximum Recommended Daily Dose: | 0.957 |
Skin Sensitization: | 0.966 | Carcinogencity: | 0.07 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.014 |
Respiratory Toxicity: | 0.91 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003126 | 0.661 | D02JNM | 0.233 | ||||
ENC003943 | 0.623 | D09WYX | 0.232 | ||||
ENC002050 | 0.611 | D04QNO | 0.227 | ||||
ENC004393 | 0.595 | D0Y7IU | 0.227 | ||||
ENC004775 | 0.595 | D0K7HU | 0.225 | ||||
ENC003173 | 0.541 | D0I5DS | 0.222 | ||||
ENC002240 | 0.489 | D09YHJ | 0.217 | ||||
ENC004392 | 0.472 | D0P0HT | 0.215 | ||||
ENC004254 | 0.435 | D0V4WD | 0.215 | ||||
ENC004774 | 0.430 | D0Y2YP | 0.214 |